Premier Regenerative treats patients with orthopedic injuries using autologous mesenchymal stem cells derived from bone marrow aspirate in one treatment session.
The stem cell therapy procedure used by the Premier uses the patented ART 21® device developed by Celling Technologies, with the support of Celling Biosciences, which is designed to maximize the highest yield of mononucleated cells.
We always appreciate patient referrals and will provide the best treatment possible for your patient. We will provide you with evaluation and treatment reports to keep you apprised of your patient’s condition and make any additional treatment recommendations that may be necessary. Please contact us if you would like more information.